-+ 0.00%
-+ 0.00%
-+ 0.00%

GALECTIN THERAPEUTICS - REACHES AGREEMENT WITH FDA ON PRIMARY ENDPOINT AND REGULATORY PATH FOR POTENTIAL FULL APPROVAL OF BELAPECTIN

Reuters·06/23/2026 11:52:29

Please log in to view news